Zafirlukast for symptomatic mild-to-moderate asthma: a 13-week multicenter study. The Zafirlukast Trialists Group.

Fish, J E; Kemp, J P; Lockey, R F; Glass, M; Hanby, L A; Bonuccelli, C M

Fish, J E; Kemp, J P; Lockey, R F; Glass, M; Hanby, L A; Bonuccelli, C M.

Affiliation

Fish JE; Jefferson Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.

Clin Ther ; 19(4): 675-90, 1997.

Article in En | MEDLINE | ID: mdl-9377612

Subject(s)

Anti-Asthmatic Agents/therapeutic use; Asthma/drug therapy; Tosyl Compounds/therapeutic use; Adolescent; Adrenergic beta-Agonists/therapeutic use; Adult; Anti-Asthmatic Agents/adverse effects; Child; Double-Blind Method; Female; Headache/chemically induced; Humans; Indoles; Leukotriene Antagonists; Male; Middle Aged; Pharyngitis/chemically induced; Phenylcarbamates; Respiratory Function Tests; Sulfonamides; Time Factors; Tosyl Compounds/adverse effects

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Asthma / Tosyl Compounds / Anti-Asthmatic Agents Type of study: Clinical_trials / Diagnostic_studies Limits: Adolescent / Adult / Child / Female / Humans / Male / Middle aged Language: En Journal: Clin Ther Year: 1997 Document type: Article Affiliation country: United States Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links